Medpace Holdings, Inc. Increase (Decrease) in Receivables
Medpace Holdings, Inc. (MEDP) reported Increase (Decrease) in Receivables of $39.36 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2026-07-23
- Medpace Holdings, Inc. increase (decrease) in receivables for the quarter ending 2026-06-30 was $47.18M, a 40.96% decline year-over-year.
- Medpace Holdings, Inc. increase (decrease) in receivables for the quarter ending 2026-03-31 was -$7.82M, a 478.06% decline year-over-year.
- Medpace Holdings, Inc. increase (decrease) in receivables for the quarter ending 2025-12-31 was $29.10M.
- Medpace Holdings, Inc. increase (decrease) in receivables for the quarter ending 2025-09-30 was -$4.86M, a 147.11% decline year-over-year.
- Medpace Holdings, Inc. increase (decrease) in receivables for fiscal 2025 was $106.22M.
- Medpace Holdings, Inc. increase (decrease) in receivables for fiscal 2024 was -$2.24M, a 104.64% decline from fiscal 2023.
- Medpace Holdings, Inc. increase (decrease) in receivables for fiscal 2023 was $48.28M, a 27.85% decline from fiscal 2022.
- Medpace Holdings, Inc. increase (decrease) in receivables for fiscal 2022 was $66.92M, a 167.87% increase from fiscal 2021.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 12 month |
|---|---|---|---|---|
| 2026-06-30 | $47.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $39.36M 10-Q · filed 2026-07-23 | $68.46M derived: sum of 3 quarters · filed 2026-07-23 | $63.60M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | -$7.82M 10-Q · filed 2026-04-23 | $21.27M derived: sum of 2 quarters · filed 2026-04-23 | $16.41M derived: sum of 3 quarters · filed 2026-04-23 | $96.32M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $29.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $24.23M derived: sum of 2 quarters · filed 2026-02-10 | $104.15M derived: sum of 3 quarters · filed 2026-07-23 | $106.22M 10-K · filed 2026-02-10 |
| 2025-09-30 | -$4.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $75.05M derived: sum of 2 quarters · filed 2026-07-23 | $77.12M 10-Q · filed 2025-10-23 | $61.84M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $79.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $81.98M 10-Q · filed 2026-07-23 | $66.71M derived: sum of 3 quarters · filed 2026-07-23 | $77.02M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $2.07M 10-Q · filed 2026-04-23 | -$13.21M derived: sum of 2 quarters · filed 2026-04-23 | -$2.89M derived: sum of 3 quarters · filed 2026-04-23 | $18.94M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | -$15.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$4.96M derived: sum of 2 quarters · filed 2026-02-10 | $16.87M derived: sum of 3 quarters · filed 2026-02-10 | -$2.24M 10-K · filed 2026-02-10 |
| 2024-09-30 | $10.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $32.15M derived: sum of 2 quarters · filed 2025-10-23 | $13.03M 10-Q · filed 2025-10-23 | $22.00M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $21.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | $2.71M 10-Q · filed 2025-07-22 | $11.68M derived: sum of 3 quarters · filed 2026-02-10 | $29.26M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | -$19.12M 10-Q · filed 2025-04-22 | -$10.15M derived: sum of 2 quarters · filed 2026-02-10 | $7.43M derived: sum of 3 quarters · filed 2026-02-10 | $24.82M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $8.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $26.55M derived: sum of 2 quarters · filed 2026-02-10 | $43.94M derived: sum of 3 quarters · filed 2026-02-10 | $48.28M 10-K · filed 2026-02-10 |
| 2023-09-30 | $17.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-22 | $34.97M derived: sum of 2 quarters · filed 2024-10-22 | $39.31M 10-Q · filed 2024-10-22 | $43.80M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | $17.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-23 | $21.73M 10-Q · filed 2024-07-23 | $26.22M derived: sum of 3 quarters · filed 2025-02-11 | $49.59M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | $4.34M 10-Q · filed 2024-04-23 | $8.83M derived: sum of 2 quarters · filed 2025-02-11 | $32.20M derived: sum of 3 quarters · filed 2025-02-11 | $33.04M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | $4.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $27.86M derived: sum of 2 quarters · filed 2025-02-11 | $28.70M derived: sum of 3 quarters · filed 2025-02-11 | $66.92M 10-K · filed 2025-02-11 |
| 2022-09-30 | $23.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-24 | $24.21M derived: sum of 2 quarters · filed 2023-10-24 | $62.44M 10-Q · filed 2023-10-24 | $62.37M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $835.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | $39.06M 10-Q · filed 2023-07-25 | $38.99M derived: sum of 3 quarters · filed 2024-02-13 | $63.69M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $38.22M 10-Q · filed 2023-04-25 | $38.16M derived: sum of 2 quarters · filed 2024-02-13 | $62.85M derived: sum of 3 quarters · filed 2024-02-13 | $64.30M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | -$64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $24.63M derived: sum of 2 quarters · filed 2024-02-13 | $26.07M derived: sum of 3 quarters · filed 2024-02-13 | $24.98M 10-K · filed 2024-02-13 |
| 2021-09-30 | $24.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | $26.14M derived: sum of 2 quarters · filed 2022-10-25 | $25.05M 10-Q · filed 2022-10-25 | $51.98M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-26 | $353.00K 10-Q · filed 2022-07-26 | $27.28M derived: sum of 3 quarters · filed 2023-02-14 | $34.41M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | -$1.09M 10-Q · filed 2022-04-26 | $25.84M derived: sum of 2 quarters · filed 2023-02-14 | $32.97M derived: sum of 3 quarters · filed 2023-02-14 | $23.74M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $26.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $34.05M derived: sum of 2 quarters · filed 2023-02-14 | $24.83M derived: sum of 3 quarters · filed 2023-02-14 | $5.53M 10-K · filed 2023-02-14 |
| 2020-09-30 | $7.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-26 | -$2.10M derived: sum of 2 quarters · filed 2021-10-26 | -$21.40M 10-Q · filed 2021-10-26 | -$6.13M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | -$9.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | -$28.52M 10-Q · filed 2021-07-27 | -$13.25M derived: sum of 3 quarters · filed 2022-02-15 | -$22.74M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | -$19.30M 10-Q · filed 2021-04-27 | -$4.03M derived: sum of 2 quarters · filed 2022-02-15 | -$13.52M derived: sum of 3 quarters · filed 2022-02-15 | $6.21M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $15.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $5.79M derived: sum of 2 quarters · filed 2022-02-15 | $25.51M derived: sum of 3 quarters · filed 2022-02-15 | $21.26M 10-K · filed 2022-02-15 |
| 2019-09-30 | -$9.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $10.24M derived: sum of 2 quarters · filed 2020-10-27 | $5.98M 10-Q · filed 2020-10-27 | $20.18M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $19.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | $15.47M 10-Q · filed 2020-07-28 | $29.67M derived: sum of 3 quarters · filed 2021-02-16 | $22.23M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | -$4.25M 10-Q · filed 2020-04-29 | $9.95M derived: sum of 2 quarters · filed 2021-02-16 | $2.50M derived: sum of 3 quarters · filed 2021-02-16 | $5.03M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $14.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $6.76M derived: sum of 2 quarters · filed 2021-02-16 | $9.29M derived: sum of 3 quarters · filed 2021-02-16 | $27.05M 10-K · filed 2021-02-16 |
| 2018-09-30 | -$7.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | -$4.92M derived: sum of 2 quarters · filed 2019-10-29 | $12.85M 10-Q · filed 2019-10-29 | $21.08M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $2.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $20.29M 10-Q · filed 2019-07-30 | $28.53M derived: sum of 3 quarters · filed 2020-02-25 | $26.59M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $17.76M 10-Q · filed 2019-04-30 | $26.00M derived: sum of 2 quarters · filed 2020-02-25 | $24.06M derived: sum of 3 quarters · filed 2020-02-25 | $18.37M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $8.24M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $6.30M derived: sum of 2 quarters · filed 2020-02-25 | $606.00K derived: sum of 3 quarters · filed 2020-02-25 | $2.90M 10-K · filed 2020-02-25 |
| 2017-09-30 | -$1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | -$7.63M derived: sum of 2 quarters · filed 2018-10-30 | -$5.34M 10-Q · filed 2018-10-30 | -$8.22M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | -$5.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | -$3.40M 10-Q · filed 2018-07-31 | -$6.28M derived: sum of 3 quarters · filed 2019-02-26 | -$14.50M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $2.29M 10-Q · filed 2018-05-01 | -$587.00K derived: sum of 2 quarters · filed 2019-02-26 | -$8.81M derived: sum of 3 quarters · filed 2019-02-26 | $6.09M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | -$2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$11.10M derived: sum of 2 quarters · filed 2019-02-26 | $3.80M derived: sum of 3 quarters · filed 2019-02-26 | $13.73M 10-K · filed 2019-02-26 |
| 2016-09-30 | -$8.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $6.68M derived: sum of 2 quarters · filed 2017-10-31 | $16.61M 10-Q · filed 2017-10-31 | $22.24M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $14.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $24.82M 10-Q · filed 2017-08-01 | $30.46M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2016-03-31 | $9.93M 10-Q · filed 2017-05-02 | $15.56M derived: sum of 2 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $5.64M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$337.00K 10-K · filed 2018-02-27 | ||
| 2015-09-30 | -$5.97M 10-Q · filed 2016-11-03 | |||
| 2014-12-31 | $1.10M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |